BTTC
Black Titan Corp
$1.12
-1.32%
$1.5M
No data for this timeframe.
Vol
Market Cap$1.5M
Cap SizeNano Cap
SEC Reports6
Recent Activity
May 15, 2026
SEC
Black Titan settled a $800,000 claim with former CEO David Lazar by issuing 800 Series B convertible preferred shares to
6-K — Impact 6/10
May 15, 2026
SEC
Black Titan Corp's F-1 registration statement (File No. 333-293538) became effective on May 14, 2026, clearing the way f
EFFECT — Impact 6/10
Apr 23, 2026
SEC
Black Titan Corp filed a 6-K to disseminate a press release outlining trends in institutional digital asset infrastructu
6-K — Impact 2/10
Latest Reports
BEARISH
6-K
6/10
Black Titan settled a $800,000 claim with former CEO David Lazar by issuing 800 Series B convertible preferred shares to
May 15, 2026
BULLISH
EFFECT
6/10
Black Titan Corp's F-1 registration statement (File No. 333-293538) became effective on May 14, 2026, clearing the way f
May 15, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
6 SEC filing reports analyzed. Sentiment: 1 bullish, 1 bearish, 0 mixed, 4 neutral. Avg impact: 3.7/10.
BEARISH
6-K
6/10
Black Titan settled a $800,000 claim with former CEO David Lazar by issuing 800 Series B convertible
May 15, 2026
BULLISH
EFFECT
6/10
Black Titan Corp's F-1 registration statement (File No. 333-293538) became effective on May 14, 2026
May 15, 2026
NEUTRAL
6-K
2/10
Black Titan Corp filed a 6-K to disseminate a press release outlining trends in institutional digita
Apr 23, 2026
NEUTRAL
6-K
3/10
Black Titan Corp issued a 6-K to report the publication of a press release highlighting key developm
Apr 15, 2026
NEUTRAL
6-K
3/10
Black Titan Corp filed a 6-K to disseminate a press release outlining strategic trends in institutio
Apr 7, 2026
NEUTRAL
6-K
2/10
Black Titan Corp filed a 6-K to disseminate a press release highlighting recent industry development
Mar 27, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.